Video

Benefits Of Standardizing Viral Vector Processes

GettyImages-1404945060 Medical Lab

Cell and Gene therapies have experienced rapid growth and advancement in the past years as more and more products advance to clinical trials and commercialization. However, many manufacturing processes are customized and require manual processes.

Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares insight into how the standardization process can help reduce project timelines and overall costs on the path to market.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene